Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Leerink Partners upgraded Align Technology Inc (NASDAQ:ALGN), citing upside opportunities throughout 2025 given gross margin expansion opportunities.
Leerink Partners将艾利科技公司（纳斯达克：ALGN）评级上调，指出在2025年期间，由于毛利率扩张机会存在上行潜力。
Align Technology — a medical device company that manufactures and sells dental aligners, scanners, and software for digital orthodontics and restorative dentistry — will benefit from improving consumer sentiment, easing comps and continued equipment traction with Lumina.
艾利科技是一家制造和销售牙齿矫正器、扫描仪和数字正畸及修复牙科软件的器械公司，将受益于消费者情绪改善、比较基数降低以及与Lumina的持续设备吸引力。
In October, Align Technology announced that it is planning to repurchase $275 million of its common stock through open market repurchases under its $1 billion stock repurchase program, which was approved by Align's Board of Directors in January 2023.
在十月，艾利科技宣布将通过其10亿美元的股票回购计划在开放市场回购27500万美元的普通股，该计划于2023年1月获得艾利董事会批准。
Also Read: What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
另请阅读：牙科企业帕特森的41亿交易对其他参与者意味着什么？
Analyst Michael Cherny still does not anticipate an entirely risk-free situation. Average selling price (ASP) pressures could lead to short-term fluctuations, and unpredictable consumer data may cause stock volatility.
分析师Michael Cherny仍然不预期完全无风险的情况。平均销售价格（ASP）压力可能导致短期波动，而不可预测的消费者数据可能导致股票波动。
However, the analyst writes the positives outweigh the negatives.
然而，分析师表示积极因素超过了消极因素。
Align has consistently outperformed competitors through innovation, competitive advantages, and relationships with dentists.
艾利通过创新、竞争优势和与牙医的关系始终优于竞争对手。
Cherny adds that the previous market perform rating reflected expectations of a weaker fiscal year in 2024 due to challenging economic conditions and uncertainty about the earnings impact of new product launches.
Cherny补充说，之前的市场表现评级反映了对2024财年由于经济条件艰难和新产品发布对收益影响的不确定性而降低的预期。
Leerink sees a clearer path for growth in fiscal 2025. Operational efficiencies will likely drive additional profit gains beyond that year.
Leerink认为2025财年增长的前景更加清晰。运营效率可能会在这一年之后推动额外的利润增长。
Leerink has upgraded Align Technology from Market Perform to Outperform, with a price target of $280 from $235.
Leerink将艾利科技的评级从市场表现上调至跑赢大盘，目标价格从235美元提升至280美元。
In the third quarter, Align Tech reported adjusted EPS of $2.35, better than the consensus of $2.31, while sales increased 1.8% to $977.9 million, below the consensus of $987.34 million.
在第三季度，艾利科技报告的每股收益调整为2.35美元，优于2.31美元的共识预期，同时销售额增长1.8%，达到97790万低于98734万的共识预期。
Most recently, Align Technology received a CE Mark in Europe for Align's Invisalign Palatal Expander System.
最近，艾利科技在欧洲获得了Align的Invisalign腭扩张器系统的CE认证。
The Invisalign Palatal Expander System has also completed registration with MHRA for the United Kingdom and overseas territories.
Invisalign腭扩张器系统也已在英国和境外地区完成MHRA注册。
Price Action: Align stock is up 6.45% at $221.68 at last check Monday.
价格动态：艾利科技股票在周一最后一次检查时上涨6.45%，报221.68美元。
- XPeng Teams Up With Real-Time Innovations For Smarter EVs: Details
- 小鹏与实时创新合作，打造更智能的电动车：详情
Image: Shutterstock
图片：shutterstock
